Stem Cell Therapy For Copd Clinical Trials

Learn more about copd clinical trials around the world.

Stem cell therapy for copd clinical trials.

The food and drug administration fda hasn t approved any stem cell treatments for people with copd and clinical trials haven t advanced beyond phase ii. A study to assess the effectiveness safety and tolerability of dupilumab in patients with moderate to severe chronic obstructive pulmonary disease copd with type 2 inflammation. Remestemcel l mesoblast s lead candidate stem cell therapy for inflammatory diseases improves lung function and exercise capacity in people with chronic obstructive pulmonary disease copd and a high degree of inflammation data from a post hoc analysis of a phase 2 trial show. Phase ii is where researchers try.

But research is progressing and more clinical trials are being developed each year. The purpose of this study is to assess the safety and feasibility of mesenchymal stem cells therapy in patients with advanced chronic obstructive pulmonary disease. There have already been successes in treating blood related diseases with stem cells derived from the blood. Findings were presented in an oral presentation at the 2020 international society for cell gene therapy isct.

To get more information about lung cell therapy or to begin the copd lung stem cells review process please prepare your recent pulmonary tests and medical records mri or chest ct scans and contact us today.